Pharmaceutical formulation development: Fundamental principles and processes
Author:
Thermo Fisher Scientific Content Team
Category | CDMO Services
Key takeaways
- Pharmaceutical formulation development helps to determine drug stability, bioavailability, and patient usability.
- Successful formulation development balances molecular properties, patient-centric design, and finished product quality.
- A structured formulation development process can reduce downstream manufacturing and regulatory risk.
- Early formulation strategy decisions influence clinical success and commercial scalability of the final drug product.
Drug formulation is the science of designing drug compositions that deliver active pharmaceutical ingredients safely and effectively. This discipline combines chemistry, biology, and engineering to optimize bioavailability, stability, and patient compliance, ensuring medications achieve their intended therapeutic outcomes while meeting regulatory standards.
Key principles of drug formulation development
When it comes to the end-to-end drug formulation process, there are three key considerations that scientists always keep top-of-mind:
- The need to optimize molecular properties
- The way in which a drug is formulated significantly impacts its molecular properties, including its chemical structure, solubility, stability, and bioavailability. By tailoring the formulation in various ways, pharmaceutical scientists can help to optimize the drug’s delivery, ensuring that patients receive the right dose of the medication and adequately experience its intended therapeutic effects.
- The importance of patient centricity
- Medications come in various dosage forms, including tablets, capsules, liquids, creams, and injectables, each designed to cater to different patient needs and preferences. Ease of administration, taste, appearance, and the potential for side effects are all important considerations. For instance, pediatric patients may prefer liquid suspensions, whereas adults may find tablets more convenient.
- Ensuring a safe and stable finished drug product
- Drug formulators carefully select excipients that are compatible with the active pharmaceutical ingredients (APIs) and help protect them from degradation over time. Properly formulated drugs must maintain their potency and quality, reducing the likelihood of adverse effects. Additionally, the end product must meet strict regulatory guidelines in every country in which it’s distributed.
Below, we break down each of the three categories mentioned above and explore how various considerations like release profile, dosage form, and excipient choice contribute to the final drug product’s success as a commercially produced therapeutic.
What are the molecular considerations in drug formulation?
Molecular considerations are foundational to successful pharmaceutical formulation, directly impacting whether an active pharmaceutical ingredient can achieve its intended therapeutic effect. A thorough understanding of bioavailability supports optimal absorption, while pharmacokinetic insights inform effective dosing strategies. Particle properties influence dissolution performance, and chemical stability protects drug integrity across development, manufacturing, and the full product lifecycle.
Bioavailability: How effectively a drug is absorbed and utilized by the body after it’s administered through a specific route, such as oral ingestion, injection, inhalation, or topical application. Bioavailability depends on factors like drug solubility and the presence of excipients.
- Release profile: The release profile refers to the pattern or rate at which a drug is released from its dosage form into the bloodstream or target tissue. It describes how quickly and to what extent the drug becomes available for absorption and distribution after administration.
- Pharmacokinetics: Pharmacokinetics attempts to summarize what the body does to an API, such as how it absorbs, distributes, metabolizes, and eliminates a drug. Drug formulations may be designed to modify these important processes to achieve specific therapeutic goals.
- Particle size and crystallinity: The size and structure of drug particles can impact the bioavailability and solubility of the API, which can also impact dissolution and absorption rates. Smaller particle sizes and specific crystal forms can enhance a drug product’s performance.
- pH and ionic strength: The pH of a drug measures its acidity or alkalinity, and it can affect a drug’s stability, solubility, and how it interacts with the body. Ionic strength is a measure of the concentration of ions and can influence the drug’s solubility, stability, and delivery.
How does patient-centric design influence drug formulation?
Patient-centric formulation development is essential to overcoming real-world barriers that can impact medication adherence. By applying deep scientific and technical expertise, pharmaceutical teams design solutions that address challenges such as swallowing difficulties, taste concerns, and complex dosing regimens. Across the biopharma industry, this patient-focused approach is increasingly prioritized to support improved therapeutic outcomes for diverse populations with varying clinical and lifestyle needs.
- Dosage form: The physical form in which a drug is administered, such as tablets, capsules, liquid suspensions, creams, ointments, or injections. The choice of dosage form depends on factors like patient preference, route of administration, and the drug's chemical properties.
- Route of administration: The way in which the drug is introduced into the body, e.g., oral, intravenous, topical, or inhalation. The route of administration affects the drug's bioavailability and therapeutic effectiveness and can also impact the patient experience of taking a drug.
- Taste and odor: In the case of oral formulations like liquid suspensions, the taste and odor of the drug can affect the overall patient experience of taking it. Masking or modifying these characteristics may be necessary, especially for specific patient populations such as children.
- Color and appearance: The color and appearance of a drug formulation can influence patient perception and compliance. They may also serve as branding elements for the eventual drug product, so they should be carefully considered during the early formulation stages.
- Compatibility with other medications: For combination therapies, it’s important to ensure that the drug formulation is compatible with other drugs that may be administered simultaneously. Additionally, it’s essential to recognize any type of drug interaction that may impact patients.
Patient-centric oral solid dose formulation: Improving access and value across the product lifecycle
What factors determine finished drug product quality?
Finished drug product quality relies on the precise integration of multiple critical factors. Successful pharmaceutical formulation requires thoughtful excipient selection to support compatibility and stability, robust analytical and testing strategies to confirm dose uniformity, and compliant packaging and labeling solutions designed to protect product integrity throughout distribution and storage.
- Excipients: Inactive ingredients, or excipients, in drug formulations serve various functions, such as binders, fillers, lubricants, preservatives, and dye. They play a crucial role in drug formulation to ensure proper dosage form and delivery and can also help to enhance shelf life.
- Stability: The ability of a drug formulation to maintain its quality and effectiveness over time. Factors such as temperature, humidity, and light can affect stability, therefore drugs must be formulated in a certain way to address and overcome degradation challenges.
- Dose strength: The amount of API, or drug substance, in a single dosage unit. Dose strength is determined by several factors such as therapeutic needs and patient population. For example, dose strength for children will typically be less potent than dose strength for adults.
- Packaging and storage conditions: Proper packaging and storage conditions are crucial to maintaining the stability and safety of the drug over its shelf life. For example, if an API is sensitive to UV light, it should be packaged in a carrier that’s impenetrable to such factors.
- Regulatory and quality standards: Compliance with regulatory guidelines and quality standards is essential to ensuring a drug formulation’s safety, efficacy, and consistency. Formulation is a key component of the drug development process and must meet regulatory standards.
“Drug formulations address practical concerns like patient compliance, making medications easier to administer, and increasing adherence to prescribing protocols.”
Why is drug formulation important?
Drug formulation is an essential step in drug development, as it directly impacts the safety, efficacy, and patient experience of taking a drug. A well-crafted formulation ensures the APIs are delivered as intended, helping to optimize their therapeutic efficacy while minimizing side effects. Additionally, drug formulation helps to address practical concerns like patient compliance, making medications easier to administer, and increasing adherence to prescribing protocols. Additionally, it also plays a vital role in obtaining regulatory approval and patent protection, which underlines its significance in bringing new and improved therapies to market. In essence, the formulation process serves to bridge the gap between scientific breakthroughs and real-world applications, ultimately determining the impact of pharmaceutical interventions.
Given its overwhelming importance, many biopharma companies choose to partner with contract development and manufacturing organizations (CDMOs) for pharmaceutical formulation. CDMOs with years of experience can provide unparalleled industry knowledge and state-of-the-art equipment to pharmaceutical formulation projects. Moreover, collaborating with a CDMO can significantly reduce the financial burden associated with maintaining in-house formulation capabilities, allowing biopharma companies to allocate their resources toward other activities like research, clinical trials, and marketing. Quality partnerships between biopharma companies and CDMOs not only ensure reliable pharmaceutical formulation, but they also help to optimize the entire drug development journey, ultimately bolstering the biopharma company’s speed to market and competitive edge in a highly dynamic market.
For organizations navigating the complexities of pharmaceutical formulation, selecting the right CDMO partner directly impacts product quality and development timelines.
Learn more about building effective CDMO partnerships in our whitepaper: Transforming CDMO Partnerships Through a Holistic Understanding of Quality.
Summary
Pharmaceutical formulation is the art and science of designing drug products to optimize therapeutic performance, stability, and patient compliance. It involves the strategic selection of excipients, the development of appropriate dosage forms, and approaches to enhance bioavailability—while maintaining rigorous standards for quality, safety, and regulatory compliance.
Frequently asked questions about formulation development
Pharmaceutical formulation is the science of designing drug products to optimize how active ingredients are delivered, absorbed, and utilized in the body. It brings together strategic excipient selection, thoughtful dosage form development, and stability optimization to help ensure safe, effective therapies are consistently delivered to patients.
The goal of pharmaceutical formulation development is to design a drug product that delivers the active pharmaceutical ingredient (API) safely and effectively, while maintaining stability, quality, and patient usability throughout its intended shelf life.
Formulation development impacts bioavailability by influencing solubility, dissolution, and drug release profiles—helping to optimize how an API is absorbed and performs in the body.
Formulation development typically begins in the early preclinical stages and continues alongside clinical development and commercial scale-up, evolving as data on safety, efficacy, and manufacturability emerge.
Patient-centric formulation development helps improve adherence and treatment outcomes by addressing real-world considerations such as dosing convenience, route of administration, and tolerability across diverse patient populations.
